Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.68 |
| ▸ | DHCR24 | Q15392 | 8/20 | 0.67 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.62 |
| ▸ | MAPT | P10636 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.62 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.46 |
| ▸ | PGR | P06401 | 1/20 | 0.46 |
| ▸ | VDR | P11473 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | AR | P10275 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28364466 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL14419156 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL29592490 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL1703700 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL10149106 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL10000314 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL665862 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL21748185 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL22150349 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 | |
| SCHEMBL18109189 | 1.00 | TRPV1 (0.78) | TRPV1CYP3A4DHCR24ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11065263-B2 | Sterol composition in pumpkin seed oil and application thereof, and drug for treating benign prostatic hyperplasia | HUNAN ZHONGKEWENTAI BIO-TECH CO. LTD (CN) | 2021-07-20 | — | — | US | claimed |
| US-12551519-B2 | Extraction system and method for organic metabolites | VCENNA TECH & LABS INC (CA) | 2026-02-17 | — | — | US | disclosed |
| US-20240123005-A1 | EXTRACTION SYSTEM AND METHOD FOR ORGANIC METABOLITES | Etminan, Seyed Reza (CA) | 2024-04-18 | — | — | US | disclosed |
| CN-114010517-A | Coenzyme Q10 skin-care gel for moisturizing, wrinkle removing and whitening and preparation method thereof | 广东润和生物科技有限公司 | 2022-02-08 | — | — | CN | disclosed |
| CN-113332211-A | Plant soft mask powder for whitening skin, removing acnes and resisting aging and preparation method thereof | 卢云龙 | 2021-09-03 | — | — | CN | disclosed |
| CN-109528806-B | Sterol composition in pumpkin seed oil, application thereof and medicine for treating prostatic hyperplasia | 刘东波 | 2021-08-06 | — | — | CN | disclosed |
| EP-3673751-A1 | CYCLOTOSTEROL PHYTOSTEROL PHYTOSTANOLE COMPOSITION DERIVED FROM RAPE SEED | Verbio Vereinigte Bioenergie AG (DE) | 2020-07-01 | — | — | EP | disclosed |
| EP-3287014-B1 | PROCESS FOR PRODUCING A PHYTOSTEROL-PHYSTOSTANOL COMPOSITION | VERBIO VER BIOENERGIE AG (DE) | 2020-02-26 | — | — | EP | disclosed |
| CN-101544678-B | Use of ergosta-7, 22-dien-3 beta-ol and its formula | VITA GREEN BIOTECHNOLOGY CO LTD | 2014-05-14 | — | — | CN | disclosed |
| CN-101544678-B | Use of ergosta-7, 22-dien-3 beta-ol and its formula | VITA GREEN BIOTECHNOLOGY CO LTD | 2014-05-14 | — | — | CN | disclosed |
| CN-101544678-A | Use of ergosta-7, 22-dien-3 beta-ol and its formula | VITA GREEN BIOTECH CO LTD | 2009-09-30 | — | — | CN | disclosed |
| CN-101544678-A | Use of ergosta-7, 22-dien-3 beta-ol and its formula | VITA GREEN BIOTECH CO LTD | 2009-09-30 | — | — | CN | disclosed |
| EP-1051075-B1 | BIOLOGICAL PLANT PROTECTION AGENT WITH RESISTANCE-PROMOTING ACTION AND METHOD FOR PRODUCING SAME | POLUS HORST (DE) | 2004-04-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11065263-B2 | Sterol composition in pumpkin seed oil and application thereof, and drug for treating benign prostatic hyperplasia | CYP17A1, HSD17B7, BPHL | TRPV1 4220/4885CYP3A4 2357/4885DHCR24 99/4885 |
| US-12551519-B2 | Extraction system and method for organic metabolites | SHH, WNT1, WNT3A | TRPV1 926/4885CYP3A4 404/4885DHCR24 555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.